[1]Rice LB.Federal funding for the study of antimicrobial resistance in nosocomial pathogens:no ESKAPE[J].J Infect Dis,2008,197(8):1079-1081. [2]Boucher HW,Talbot GH,Bradley JS,et al.Bad bugs,no drugs:no ESKAPE! An update from the Infectious Diseases Society of America[J].Clin Infect Dis,2009,48(1):1-12. [3]Infectious Diseases Society of America.The 10×20 Initiative:pursuing a global commitment to develop 10 new antibacterial drugs by 2020[J].Clin Infect Dis,2010,50(8):1081-1083. [4]Kumarasamy KK,Toleman MA,Walsh TR,et al.Emergence of a new antibiotic resistance mechanism in India,Pakistan,and the UK:a molecular,biological,and epidemiological study[J].Lancet Infect Dis,2010,10(9):597-602. [5]Berg P,Lindhardt B.The role of procalcitonin in adult patients with community-acquired pneumonia-a systematic review[J].Dan Med J,2012,59:A4357 [6]Weatherall C,Paoloni R,Gottlieb T.Point-of-care urinary pneumococcal antigen test in the emergency department for community acquired pneumonia[J].Emerg Med J,2008,25:144-148. [7]Sopena N,Sabrià M.Multicenter study of hospital-acquired pneumonia in non-ICU patients[J].Chest,2005,127:213-219. [8]Lieberman D,Shimoni A,Shemer-Avni Y,et al.Respiratory viruses in adults with community-acquired pneumonia[J].Chest,2010,138:811-816. [9]陈旭岩,于学忠,沈洪,等.北京地区三级甲等综合医院急诊科成人重症社区获得性肺炎诊治现况和致病原调查[J].中国急救医学,2013,33(6):511-515. [10]中国医师协会急诊医师分会.急诊成人社区获得性肺炎诊治专家共识[J].中国急救医学,2011,31(10):865-871. |